BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4364826)

  • 1. Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA).
    Palese P; Schulman JL; Bodo G; Meindl P
    Virology; 1974 Jun; 59(2):490-8. PubMed ID: 4364826
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility of different strains of influenza A virus to the inhibitory effects of 2-deoxy-2,3-dehydro-n-trifluoracetylneuraminic acid (FANA).
    Schulman JL; Palese P
    Virology; 1975 Jan; 63(1):98-104. PubMed ID: 1167433
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid.
    Meindl P; Bodo G; Palese P; Schulman J; Tuppy H
    Virology; 1974 Apr; 58(2):457-63. PubMed ID: 4362431
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action.
    Palese P; Compans RW
    J Gen Virol; 1976 Oct; 33(1):159-63. PubMed ID: 978183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid on Myxovirus-neuraminidases and the replication of influenza- and Newcastle disease virus].
    Meindl P; Bodo G; Lindner J; Palese P
    Z Naturforsch B; 1971 Aug; 26(8):792-7. PubMed ID: 4399278
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of synthetic inhibitors of neuraminidase and hemagglutinin for studying the functional role of active subunits of membranes of myxo- and paramyxoviruses].
    Zakstel'skaia LIa; Molibog EV; Iakhno MA; Evstigneeva NA; Isachenko VA
    Vopr Virusol; 1972; 17(2):223-8. PubMed ID: 4337525
    [No Abstract]   [Full Text] [Related]  

  • 7. Applications of a synthetic neuraminidase substrate.
    Palese P; Bucher D; Kilbourne ED
    Appl Microbiol; 1973 Feb; 25(2):195-201. PubMed ID: 4121031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemolysis by Sendai virus: lack of requirement for neuraminidase.
    Neurath AR; Vernon SK; Hartzell RW; Rubin BA
    J Gen Virol; 1972 Aug; 16(2):245-9. PubMed ID: 4342042
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of Respiratory syncytial, parainfluenza 3 and measles viruses by 2-deoxy-D-glucose.
    Hodes DS; Schnitzer TJ; Kalica AR; Camargo E; Chanock RM
    Virology; 1975 Jan; 63(1):201-8. PubMed ID: 163047
    [No Abstract]   [Full Text] [Related]  

  • 10. Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen.
    Macdonald SJ; Watson KG; Cameron R; Chalmers DK; Demaine DA; Fenton RJ; Gower D; Hamblin JN; Hamilton S; Hart GJ; Inglis GG; Jin B; Jones HT; McConnell DB; Mason AM; Nguyen V; Owens IJ; Parry N; Reece PA; Shanahan SE; Smith D; Wu WY; Tucker SP
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4542-9. PubMed ID: 15561823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of RNA virus replication in vitro by 3-deazacytidine and 3-deazauridine.
    Khare GP; Sidwell RW; Huffman JH; Tolman RL; Robins RK
    Proc Soc Exp Biol Med; 1972 Jul; 140(3):880-4. PubMed ID: 4339065
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-influenza virus activity of biflavonoids.
    Miki K; Nagai T; Suzuki K; Tsujimura R; Koyama K; Kinoshita K; Furuhata K; Yamada H; Takahashi K
    Bioorg Med Chem Lett; 2007 Feb; 17(3):772-5. PubMed ID: 17110111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inability of isoquinoline derivatives to inhibit virus neuraminidase activity.
    Shinkai K; Nishimura T
    J Gen Virol; 1972 Aug; 16(2):227-9. PubMed ID: 5072367
    [No Abstract]   [Full Text] [Related]  

  • 14. [Function of neuraminidase of influenza virus and anti influenza compounds by its inhibition].
    Yamashita M
    Tanpakushitsu Kakusan Koso; 2009 Aug; 54(10):1284-91. PubMed ID: 19663256
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect on influenza virus of a modified Francis inhibitor and its acetone-soluble fraction. 3. Experiments on the mouse lung.
    Hollós I
    Acta Microbiol Acad Sci Hung; 1969; 16(2):113-22. PubMed ID: 5377767
    [No Abstract]   [Full Text] [Related]  

  • 16. MTT colorimetric assay system for the screening of anti-orthomyxo- and anti-paramyxoviral agents.
    Watanabe W; Konno K; Ijichi K; Inoue H; Yokota T; Shigeta S
    J Virol Methods; 1994 Jul; 48(2-3):257-65. PubMed ID: 7989442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ching-fang-pai-tu-san inhibits the release of influenza virus.
    Hsieh CF; Yen HR; Liu CH; Lin S; Horng JT
    J Ethnopharmacol; 2012 Dec; 144(3):533-44. PubMed ID: 23041224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potent and selective inhibition of parainfluenza 1 (Sendai) virus by new 6-oxiranyl-, 6-methyloxiranyluracils, and 4(3H)-pyrimidinone derivatives.
    Saladino R; Danti MC; Mincione E; Crestini C; Palamara AT; Savini P; Marini S; Botta M
    Bioorg Med Chem Lett; 1998 Jul; 8(14):1833-8. PubMed ID: 9873443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory virus inhibitors in the colostrum of Chinese donors.
    Shortridge KF; Wong R
    J Trop Med Hyg; 1974 May; 77(5):94-102. PubMed ID: 4366198
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors.
    Mishin VP; Novikov D; Hayden FG; Gubareva LV
    J Virol; 2005 Oct; 79(19):12416-24. PubMed ID: 16160169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.